RIL
NGNE icon

Rothschild Investment LLC’s Neurogene NGNE Stock Holding History

Rothschild Investment LLC’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67K Buy
53
+8
+18% +$220 ﹤0.01% 2835
2026
Q1 		$907 Buy
45
+5
+13% +$97 ﹤0.01% 2918
2025
Q4 		$824 Hold
40
– – ﹤0.01% 2743
2025
Q3 		$693 Sell
40
-15
-27% -$301 ﹤0.01% 2730
2025
Q2 		$822 Buy
+55
New +$863 ﹤0.01% 2565

Other funds holding NGNE

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
RBI
Raiffeisen Bank International Vienna, Austria $8.53B AUM 46.94% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

Rothschild Investment LLC's NGNE Position: Q2 2026 in Review

Rothschild Investment LLC increased its Neurogene (NGNE) stake by 18% in Q2 2026, buying an estimated $220 and bringing the position to 53 shares worth $1.67K. The position accounts for ﹤0.01% of the portfolio, ranked #2835.

Rothschild Investment LLC first reported a position in NGNE in Q2 2025 and has held it in 5 quarters since. 22 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

  • Rothschild Investment LLC held 53 shares of Neurogene worth $1.67K as of Q2 2026.
  • Rothschild Investment LLC bought 8 Neurogene shares in Q2 2026, an estimated $220.
  • Neurogene made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2835 holding.
  • Rothschild Investment LLC first reported a position in Neurogene in Q2 2025 and has held it in 5 quarters since.
  • 22 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.